glutathione iv and parkinson's Therapy Glutathione S-transferase: A keystone in

Dorochow, E., Khm, M., Hahnefeld, L

Patients should be reviewed 812 weeks after commencing treatment to assess: Symptomatic improvement, particularly resolution of fatigue and neurological symptoms Haematological response (normalisation of haemoglobin and mean cell volume) Reticulocyte count typically rises within one week, indicating bone marrow response Repeat serum B12 testing is generally not useful after starting parenteral therapy, as levels remain elevated for months

This blend is designed for a multi-phase regenerative response, targeting both accelerated healing within the body and improved skin health

& Asanuma, M

This level suits researchers primarily interested in metabolic health improvements like insulin sensitivity and lipid panel normalization, where extreme weight loss is not the primary goal